Y-mAbs Therapeutics, Inc. YMAB shares soared 13.8% in the last trading session to close at $5.70. The move was backed…
Commercial-stage biopharma stock Y-mAbs Therapeutics Inc (US:YMAB), reported fourth quarter and full year 2022 results on Thursday post market, sending…